> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# EUA Revoked on Veklury After sNDA Approved
- URL: https://www.fdaweb.com/eua-revoked-on-veklury-after-snda-approved/
- Published: 2022-07-26T12:00:00.000Z
- Updated: 2026-09-14T17:53:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152365

*Federal Register* notice: FDA has revoked the Emergency Use Authorization (EUA) issued to Gilead Sciences for Veklury (remdesivir) for treating Covid-19 in adults and pediatric patients. The revocation follows FDA approval of a supplemental NDA for Veklury, which expanded the approved indication to cover the EUA-intended population. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-07-26/pdf/2022-15956.pdf?ref=fdaweb.com).